Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring news

Show

From To
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

Protease inhibitors may not be the best class of drug for people newly diagnosed with HIV to start treatment with, if they wish to quickly

Published
12 May 2017
By
Gus Cairns
New Study Reveals why people with HIV are more likely to develop Emphysema

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema in their lifetime. Now, new research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Published
10 May 2017
From
Weill Cornell Medicine
PrEP should be given to all breastfed babies, researchers say

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time

Published
05 April 2017
By
Gus Cairns
Accelerated linkage to HIV care improves retention in care by a third

Close to 60% of adults benefiting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral therapy (ART) initiation and SMS appointment reminders were retained

Published
21 February 2017
By
Carole Leach-Lemens
Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000

A study by the US Centers for Disease Control and Prevention (CDC) presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle found

Published
18 February 2017
By
Gus Cairns
Commentary on U=U campaign - Follow Up on previous article 'On Fear, Infectiousness and Undetectability'

Last week, GNP+ published a statement offering an alternative perspective on the messaging of campaigns on the uninfectiousness of people living with HIV who achieve viral suppression, including the U=U (Undetectable = Untransmittable) campaign. Following reactions from supporters of the campaign, GNP+ releases the following statement clarifying our position on this important issue.

Published
15 February 2017
From
GNPPlus
Changes in viral suppression over time reveal disparities in HIV care in the United States

Sustained viral suppression over the course of a year may be a better measure than the most recent viral load test result when it comes to understanding

Published
15 February 2017
By
Liz Highleyman
Treatment-as-prevention study sees substantial levels of transmitted drug resistance in participants, but no impact on treatment

A study of the prevalence of transmitted drug resistance in participants in the ANRS 12249 trial of treatment as prevention, which reported its main results at the International

Published
15 February 2017
By
Gus Cairns
People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report

Published
16 January 2017
By
Michael Carter
← First12345...57Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.